ADRAlert

ADRAlert quantifies drug safety by analyzing multilayer drug–gene–adverse drug reaction (ADR) networks with machine learning across 1,156 distinct ADRs.

Key Features:

• Multilayer Network Analysis: Leverages an advanced machine learning model to deconstruct and analyze drug–gene–ADR multilayer interactions.
• ToxicityScore Parameter: Provides a ToxicityScore that quantifies the overall safety profile of a drug for comparative prioritization.
• Gene–ADR Interaction Quantification: Determines association strengths for a dataset comprising 3,807,631 gene–ADR interactions.
• ADR Coverage: Evaluates safety signals across 1,156 distinct adverse drug reactions.
• Machine Learning Framework and Benchmarking: Synthesizes clinical and non-clinical data within a machine learning framework and compares the performance of various machine learning methods.

Scientific Applications:

• Drug Safety Assessment: Generates reproducible quantitative profiles to assess potential adverse drug reactions and overall safety.
• ADR Prediction and Mechanism Analysis: Supports prediction of ADRs and analysis of underlying gene–ADR mechanisms using machine learning-derived associations.
• Enhancing Drug Discovery: Informs prioritization of safer therapeutic candidates to reduce late-stage attrition due to adverse reactions.

Methodology:

Employs a machine learning framework that synthesizes clinical and non-clinical data and focuses on three explicit tasks: drug–ADR benchmark data creation, drug–ADR prediction, and ADR mechanism analysis, with comparison of various machine learning methods.